Initial Focus
Sterile IV fluids
Sterile large-volume parenteral IV fluids intended for use across hospitals and other clinical environments, subject to manufacturing readiness and regulatory approval.
About Biogenix
A calling to heal through purposeful pharmaceutical manufacturing.
Biogenix is a Zimbabwean pharmaceutical manufacturing company being developed to strengthen access to quality-assured essential medicines through modern technology, responsible manufacturing and a patient-centred approach.
Who We Are
Building local capability around medicines that healthcare systems depend on.
Biogenix is a Zimbabwe-focused pharmaceutical manufacturing company being developed to produce essential sterile medicines for hospitals, clinics and healthcare providers.
The company’s first strategic platform is the proposed manufacture of large-volume parenteral IV fluids. Over time, Biogenix intends to develop a carefully selected portfolio of generic injectable medicines based on clinical need, technical feasibility, market requirements and regulatory approval.
Biogenix seeks to combine pharmaceutical science, appropriate manufacturing technology, rigorous quality systems and an understanding of healthcare needs to support more dependable access to essential medicines.
- 01
Essential medicines
A focused direction shaped around medicines that hospitals, clinics and healthcare providers depend on.
- 02
Local manufacturing capability
Building appropriate technical, quality and production capability closer to the healthcare systems it is intended to support.
- 03
Long-term African ambition
Developing responsibly in Zimbabwe with a long-term view toward suitable regional healthcare needs.
Our Purpose
Strengthening access begins with building dependable manufacturing capability.
Biogenix is being developed to help address the need for reliable access to essential hospital medicines through a focused, responsible manufacturing strategy.
Long-Term Direction
Selected generic injectables
Expansion into selected generic injectable medicines guided by healthcare needs, technical capability, market assessment and regulatory requirements.
Mission and Vision
Purpose that guides the company being built.
To manufacture quality-assured essential medicines that help healthcare professionals deliver safe, effective and reliable patient care.
To become a trusted African pharmaceutical manufacturer known for quality, reliability, innovation and patient-centred manufacturing.
Our mottoA Calling to Heal
What Guides Us
Principles for building a responsible pharmaceutical company.
- 01
Patient First
Every product ultimately serves a patient, and patient wellbeing must remain central to decision-making.
- 02
Quality
Quality should be designed into every stage of product development and manufacturing.
- 03
Integrity
Biogenix seeks to operate with transparency, accountability and professional ethics.
- 04
Reliability
Healthcare systems depend on consistent standards and dependable medicine supply.
- 05
Innovation
Biogenix aims to use appropriate technology to improve manufacturing capability and product quality.
- 06
Collaboration
Progress requires constructive relationships with healthcare professionals, regulators, suppliers, technical partners and communities.
- 07
Responsibility
Biogenix seeks to create lasting value for patients, employees, communities and the environment.
Our Development Path
A phased approach to building pharmaceutical manufacturing capability.
Each stage is dependent on the necessary technical, operational and regulatory requirements. The sequence does not indicate completion or a committed timeline.
Stage 1
Foundation
Establish the company, manufacturing strategy, technical partnerships and development framework.
Stage 2
Manufacturing and Regulatory Readiness
Develop the proposed facility, quality systems, technical processes and required regulatory submissions.
Stage 3
Initial Commercial Portfolio
Introduce approved IV-fluid products only after manufacturing readiness and applicable regulatory authorization.
Stage 4
Portfolio Expansion
Develop selected generic injectable medicines based on healthcare need, technical feasibility and regulatory approval.
Stage 5
Regional Growth
Build long-term capability for responsible expansion into suitable African markets.
Responsible Growth
Manufacturing medicines responsibly means considering patients, people and the environment.
Biogenix aims to consider responsible practices as its proposed operations, supply relationships and future workforce are developed.
Responsible Operations
- Responsible water use
- Energy efficiency
- Efficient manufacturing processes
- Controlled waste segregation and disposal
- Environmental compliance
Responsible Supply
- Responsible sourcing
- Supplier qualification
- Appropriate packaging choices
- Material traceability
- Long-term supplier relationships
Skills and Communities
- Local employment potential
- Pharmaceutical skills development
- Technical training
- Collaboration with institutions
- Long-term contribution to healthcare capability
These themes express the direction being considered for Biogenix’s development. They are not claims of completed programmes, measured outcomes or environmental certification.
Work With Us
Building the future of pharmaceutical manufacturing through shared purpose.
Biogenix welcomes conversations with healthcare institutions, technical partners, qualified suppliers, development partners and professionals interested in contributing to its manufacturing vision.